Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease-Reference-Cited by-同舟云学术

Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease

Published:2022-09-01 Issue:3 Volume:54 Page:461-469
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Galli Mattia,Rollini Fabiana,Been Latonya,Zenni Martin M.,Angiolillo Dominick J.,Franchi Francesco^ORCID

Funder

College of Medicine, University of Florida

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-022-02696-4.pdf

Reference34 articles.

1. Capodanno D, Angiolillo DJ (2020) Antithrombotic therapy for atherosclerotic cardiovascular disease risk mitigation in patients with coronary artery disease and diabetes mellitus. Circulation 142(22):2172–2188

2. Patti G, Cavallari I, Andreotti F, Calabrò P, Cirillo P, Denas G et al (2019) Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs. Nat Rev Cardiol 16(2):113–130

3. Rollini F, Franchi F, Muñiz-Lozano A, Angiolillo DJ (2013) Platelet function profiles in patients with diabetes mellitus. J Cardiovasc Transl Res 6(3):329–345

4. Franchi F, Rollini F, Aggarwal N, Hu J, Kureti M, Durairaj A et al (2016) Pharmacodynamic comparison of prasugrel versus ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease: the OPTIMUS (optimizing antiplatelet therapy in diabetes mellitus)-4 study. Circulation 134(11):780–792

5. Angiolillo DJ, Jakubowski JA, Ferreiro JL, Tello-Montoliu A, Rollini F, Franchi F et al (2014) Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease. J Am Coll Cardiol 64(10):1005–1014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital;Journal of Thrombosis and Thrombolysis;2024-09-06

2. Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions;Frontiers in Cardiovascular Medicine;2023-03-03

3. Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation;Frontiers in Cardiovascular Medicine;2022-11-22